<DOC>
	<DOCNO>NCT02231736</DOCNO>
	<brief_summary>The purpose study determine whether glycemic control ( HbA1c ) link chromosomal damage type 2 Diabetes patient</brief_summary>
	<brief_title>Chromosomal Damage Type 2 Diabetes Patients ( MIKRODIAB )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 Diabetes ( T2DM ) Sex : female Age : &gt; 30years Medication : oral antidiabetic and/or Insulin therapy Constant nutritional behavior , constant physical activity , constant weight last 4 week Nonsmoking least 1 year Patients type 1 DM Age : &lt; 30years Pregnant lactate woman Participation another clinical trial Change medication regard metabolic parameter within last 4 week Significant cardiovascular damage NYHA &gt; III Liver disease threetimes high transaminase value Chronic kidney disease serum creatinine &gt; 2 mg/dl Dialysis HIV positive History chronic alcohol abuse last two year History cancer , stroke , organ transplantation Male</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Chromosomal damage</keyword>
	<keyword>Micronuclei</keyword>
	<keyword>DNA damage</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Comet Assay</keyword>
	<keyword>Glycemic control</keyword>
</DOC>